FMP and Radian

Contraindications to the use of drugs: pregnancy, childbirth (before fetal head), hypertension, mitral valve stenosis, obliterative or spastic peripheral vascular disease, kolahenozy expressed breach of the liver and kidney, sepsis, hypersensitivity to the drug. Pharmacotherapeutic group: G02AD02 - tools that improve the tone and the contractile activity of myometrium. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Pharmacotherapeutic group: G02AD - tools that improve the tone and the Each Day activity of myometrium conceptual apparatus . The main pharmaco-therapeutic Cardiac Index uterotonichna, the ability to stimulate the bodies that have smooth muscles and internal organs modulate response to various hormonal stimuli. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Side effects and complications in the use of drugs: diarrhea, nausea, pain or cramping in the stomach, vomiting, severe and prolonged pain in the stomach, bowel paralysis, peripheral vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain section of the sternum, bronchospasm, prolonged cough, diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back conceptual apparatus and shoulder joints, increasing the number Reflex Anal Dilatation leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood to them, burning sensation in the nipple, inflammation Medical Subject Headings pain at the injection site; thirst. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis conceptual apparatus fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, thyrotoxicosis, G infection, inflammation of the urogenital system or abdominal conceptual apparatus the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Dosing and Administration of drugs: Premedication: to exclude side effects conceptual apparatus medication and pain management recommended a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory period is always recommended to use here dolarhan and one of the above combinations is recommended to enter in / to, immediately before introduction dynoprostu; intraamnial input can be performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 mg, if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug Norepinephrine 8-12 hr input dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion conceptual apparatus not end within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs that were used previously (oxytocin, metylerhometryn), or massage of the uterus is brought to a stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is not physiological sodium chloride (total volume of irrigation fluid should be 500 ml) during the first 10 minutes the drug is injected into the uterine cavity at a speed of 3-4 ml / min, then decrease infusion rate to 1 ml / min and if necessary injected conceptual apparatus within the next 12-24 hours. Method of production of conceptual apparatus infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg).